What is Aclarion Inc (ACON) stock price today?

Aclarion Inc (ACON) currently trades at $3.26 per share. The stock has a market capitalization of $8.03M and a P/E ratio of —x.

Is ACON stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Aclarion Inc has a Smart Value Score of 33/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -44.40.

What is Aclarion Inc's revenue and earnings?

Aclarion Inc has trailing twelve-month (TTM) revenue of $75730.00 with profit margins of 0.00%. Earnings per share (EPS) is $-13.61.

Is Aclarion Inc financially healthy?

Aclarion Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -44.40 places it in the distress.

ACON

Aclarion Inc

NASDAQ: ACON · HEALTHCARE · HEALTH INFORMATION SERVICES

$3.26

-3.26% today

Updated 2026-04-29

Market cap

$8.03M

P/E ratio

—

P/S ratio

105.99x

EPS (TTM)

$-13.61

Dividend yield

—

52W range

$2 – $12

Volume

0.1M

Market cap

$8.03M

P/E ratio

—

P/S ratio

105.99x

EPS (TTM)

$-13.61

Dividend yield

—

52W range

$2 – $12

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

6.7

Growth

5.3

Quality

C+

2.5

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-44.4

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$7.00

+114.72%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 80.60% QoQ

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -44.40 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-1.71M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$60444.00	$75404.00	$45724.00	$75730.00	$75730.00
Net income	$-7.07M	$-4.91M	$-6.99M	$-7.23M	$-1.89M
EPS	—	—	—	—	$-13.61
Free cash flow	$-5.52M	$-3.77M	$-5.59M	$-7.16T	$-1.71M
Profit margin	-11,694.45%	-6,513.41%	-15,293.78%	-9,551.87%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ACON	$8.03M	33	6.7	2.5	5.0	5.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Aclarion Inc trades at $3.26. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -44.40, it sits in the distress. TTM revenue stands at $75730.00.

Frequently asked questions

What is Aclarion Inc's stock price?

Aclarion Inc (ACON) trades at $3.26.

Is Aclarion Inc overvalued?

Smart Value Score 33/100 (Grade F, Strong Sell).

What is the price target of Aclarion Inc (ACON)?

The analyst target price is $7.00, representing +114.7% upside from the current price of $3.26.

What is Aclarion Inc's revenue?

TTM revenue is $75730.00.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-44.40 — distress.

Company info

SectorHEALTHCARE

IndustryHEALTH INFORMATION SERVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.aclarion.com

Quick metrics

P/S ratio105.99x

ROE-104.80%

Beta1.14

50D MA$3.18

200D MA$5.65

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ACON vs LLY →ACON vs JNJ →ACON vs ABBV →Stock screener →